Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Liu, Jun ^a,b   Xu, Xinnv ^c   Feng, Xuequan ^c   Zhang, Biao ^b   Wang, Jinhuan ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN HUANHU HOSPITAL   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

bFGF; Glioblastoma multiforme; IL 6; STAT3

Indexed keywords

CYCLIN D1; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; JANUS KINASE 2; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT3 PROTEIN; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN, HUMAN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEPOLARIZATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BRAIN TUMOR; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 80052571587     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-80     Document Type: Article

References (38)

1. Glioblastoma. Miller CR, Perry A, Arch Pathol Lab Med 2007 131 397 406 17516742
2. Molecular targets of glioma invasion. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME, Cell Mol Life Sci 2007 64 458 478 10.1007/s00018-007-6342-5 17260089
3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Cancer Genome Atlas Research Network, Nature 2008 455 1061 1068 10.1038/nature07385 18772890
4. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Ahluwalia MS, de Groot J, Liu WM, Gladson CL, Cancer Lett 2010 298 139 149 10.1016/j.canlet.2010.08.014 20947248
5. Molecular pathology of malignant gliomas. Louis DN, Annu Rev Pathol 2006 1 97 117 10.1146/annurev.pathol.1.110304.100043 18039109
6. The potential role of basic fibroblast growth factor in the transformation of cultured primary human fetal astrocytes and the proliferation of human glioma (U-87) cells. Gately S, Soff GA, Brem S, Neurosurgery 1995 37 723 730 10.1227/00006123-199510000-00017 8559302
7. Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Fukui S, Nawashiro H, Otani N, Ooigawa H, Nomura N, Yano A, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K, Cancer 2003 97 3061 3067 10.1002/cncr.11450 12784342 (Pubitemid 36676261)
8. Adenovirus-mediated delivery of bFGF small interfering RNA increases levels of connexin 43 in the glioma cell line, U251. Zhang B, Feng X, Wang J, Journal of Experimental Clinical Cancer Research 2010 29 3 10.1186/1756-9966-29- 3 20074329
9. Combined Antitumor Effect of Ad-bFGF-siRNA and Ad-Vpr on the Growth of Xenograft Glioma in Nude Mouse Model. Zhang B, Feng X, Wang J, Pathol Oncol Res 2011 17 237 242 10.1007/s12253-010-9303-5 20848251
10. The STATs of cancer - new molecular targets come of age. Yu H, Jove R, Nat Rev Cancer 2004 4 97 105 10.1038/nrc1275 14964307 (Pubitemid 38198738)
11. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Abou-Ghazal M, Yang DS, Qiao W, Clin Cancer Res 2008 14 8228 8235 10.1158/1078-0432.CCR-08-1329 19088040
12. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F, Biochem J 2003 374 1 20 10.1042/BJ20030407 12773095 (Pubitemid 37046923)
13. Interleukins and STAT Signaling. Haque SJ, Sharma P, Vitam Horm 2006 74 165 206 17027515
14. STAT proteins and transcriptional responses to extracellular signals. Horvath CM, Trends Biochem Sci 2000 25 496 502 10.1016/S0968-0004(00)01624-8 11050435
15. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Yu CL, Meyer DJ, Campbell GS, Science 1995 269 81 83 10.1126/science.7541555 7541555
16. A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Li L, Shaw PE, Biochem Biophys Res Commun 2004 322 1005 1011 10.1016/j.bbrc.2004.08.014 15336564 (Pubitemid 39164453)
17. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Brantley EC, Benveniste EN, Mol Cancer Res 2008 6 675 684 10.1158/1541-7786.MCR-07-2180 18505913
18. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ, Oncogene 2002 21 8404 8413 10.1038/sj.onc.1206047 12466961 (Pubitemid 36054883)
19. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Lo HW, Cao X, Zhu H, Ali-Osman F, Clin Cancer Res 2004 14 6042 6054
20. IL-6 is required for glioma development in a mouse model. Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA, Aguzzi A, Weis J, Oncogene 2004 23 3308 3316 10.1038/sj.onc.1207455 15064729 (Pubitemid 38669820)
21. Down-regulation of Stat3 induces apoptosis of human glioma cell: a potential method to treat brain cancer. Ren W, Duan Y, Yang Y, Ji Y, Chen F, Neurol Res 2008 30 297 301 10.1179/016164107X230784 17716392 (Pubitemid 351769426)
22. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells. Cuevas P, D'az-Gonza'lez D, Sa'nchez I, Neurol Res 2006 28 127 130 10.1179/016164106X97982 16551428
23. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Arese M, Chen Y, Florkiewicz RZ, Gualandris A, Shen B, Rifki DB, Mol Biol Cell 1999 10 1429 1444 10233154 (Pubitemid 29230900)
24. Fibroblast growth factors are translocated to the nucleus of human endothelial cells in a microtubule- and lysosome-independent pathway. Hu G, Kim H, Xu C, Riordan JF, Biochem Biophys Res Commun 2000 273 551 556 10.1006/bbrc.2000.2978 10873643 (Pubitemid 30599023)
25. Fibroblast growth factor signaling during early vertebrate development. Bottcher RT, Niehrs C, Endocr Rev 2005 26 63 77 10.1210/er.2003-0040 15689573 (Pubitemid 40209387)
26. Mitogen-activated protein kinases in apoptosis regulation. Wada T, Penninger JM, Oncogene 2004 23 2838 49 10.1038/sj.onc.1207556 15077147 (Pubitemid 38638846)
27. Phosphorylated Extracellular Signal-regulated Kinases are Significantly Increased in Malignant Mesothelioma. de Melo M, Gerbase MW, Curran J, Pache JC, J Histochem Cytochem 2006 54 855 861 10.1369/jhc.5A6807.2006 16517979 (Pubitemid 44106863)
28. Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-regulated Kinases and STAT3. Udayakumar ST, Stratton MS, Neoplasia 2002 4 60 67 10.1038/sj.neo.7900207 11922392 (Pubitemid 34075891)
29. Serine phosphorylation of STATs. Decker T, Kovarik P, Oncogene 2000 19 2628 2637 10.1038/sj.onc.1203481 10851062 (Pubitemid 30339219)
30. Activators and target genes of Rel/NF-kB transcription factors. Pahl HL, Oncogene 1999 18 6853 6866 10.1038/sj.onc.1203239 10602461
31. Interleukin-6 gene amplification and shortened survival in glioblastoma patients. Tchirkov A, Khalil T, Chautard EE, Br J Cancer 2007 96 474 476 10.1038/sj.bjc.6603586 17224923 (Pubitemid 46215219)
32. IL-6 is required for glioma development in a mouse model. Weissenberger J, Loeffler S, Kappeler A, Oncogene 2004 23 3308 3316 10.1038/sj.onc.1207455 15064729 (Pubitemid 38669820)
33. Persistently activated STAT3 maintains constitutive NF-kB activity in tumors. Lee H, Herrmann A, Deng JH, Cancer Cell 2009 15 283 293 10.1016/j.ccr.2009.02.015 19345327
34. Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas. Brantley EC, Benveniste EN, Mol Cancer Res 2008 6 675 684 10.1158/1541-7786.MCR-07-2180 18505913
35. SRC and STAT pathways. Haura EB, J Thorac Oncol 2006 1 403 405 10.1097/01243894-200606000-00003 17409890 (Pubitemid 47181414)
36. The Role of Src in Solid Tumors. Wheeler DL, lida M, Dunn EF, The Oncologist 2009 14 667 678 10.1634/theoncologist.2009-0009 19581523
37. Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, Hunt JD, JBC 2002 277 21237 21245 10.1074/jbc. M110955200 (Pubitemid 34952260)
38. Proteins of the bcl-2 family in apoptosis signaling: from mechanistic insights to therapeutic opportunities. Chan SL, Yu VC, Clin Exp Pharmacol Physiol 2004 31 119 128 10.1111/j.1440-1681.2004.03975.x 15008953 (Pubitemid 38338707)